FineMark National Bank & Trust’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,747
Closed -$214K 435
2024
Q3
$214K Buy
+2,747
New +$214K 0.01% 399
2023
Q3
Sell
-3,285
Closed -$235K 417
2023
Q2
$235K Buy
+3,285
New +$235K 0.01% 384
2015
Q4
Sell
-2,512
Closed -$80K 1354
2015
Q3
$80K Sell
2,512
-204
-8% -$6.5K 0.01% 506
2015
Q2
$86K Buy
2,716
+2,548
+1,517% +$80.7K 0.01% 521
2015
Q1
$6K Sell
168
-660
-80% -$23.6K ﹤0.01% 1091
2014
Q4
$29K Buy
828
+660
+393% +$23.1K ﹤0.01% 815
2014
Q3
$6K Sell
168
-336
-67% -$12K ﹤0.01% 1096
2014
Q2
$18K Sell
504
-3,582
-88% -$128K ﹤0.01% 916
2014
Q1
$133K Sell
4,086
-130
-3% -$4.23K 0.02% 388
2013
Q4
$125K Sell
4,216
-2,044
-33% -$60.6K 0.03% 390
2013
Q3
$163K Buy
6,260
+1,264
+25% +$32.9K 0.04% 335
2013
Q2
$118K Buy
+4,996
New +$118K 0.04% 369